SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey

Murhekar, Manoj; Bhatnagar, Tarun; Selvaraju, Sriram; Saravanakumar, V.; Wesley Vivian Thangaraj, Jeromie; K. Shah, Naman; Santhosh Kumar, Muthusamy; Rade, Kiran; Sabarinathan, R.; Asthana, Smita; Balachandar, Rakesh; Dipak Bangar, Sampada; Kumar Bansal, Avi; Bhat, Jyothi; Chopra, Vishal; Das, Dasarathi; Kumar Deb, Alok; Rekha Devi, Kangjam; Raj Dwivedi, Gaurav; Salim Khan, Muhammad; P. Girish Kumar, C.; Sunil Kumar, M.; Laxmaiah, Avula; Madhukar, Major; Mahapatra, Amarendra; Sundar Mohanty, Suman; Rangaraju, Chethana; Turuk, Alka; Kumar Baradwaj, Dinesh; S. Chahal, Ashrafjit; Debnath, Falguni; Haq, Inaamul; Kalliath, Arshad; Kanungo, Srikanta; Singh Kshatri, Jaya; Gandhi Jayanthi Naga Lakshmi, Gangeti; Mitra, Anindya; Nirmala, A; Venkata Prasad, Ganta; Amin Qurieshi, Mariya; Sahay, Seema; Kumar Sangwan, Ramesh; Sekar, Krithikaa; K. Shukla, Vijay; Kumar Singh, Prashant; Singh, Pushpendra; Singh, Rajeev; Sheethal Varma, Dantuluri; Viramgami, Ankit; Panda, Samiran; C. S. Reddy, D.; Bhargava, Balram; Andhalkar, Rushikesh; Chaudhury, Anshuman; Deval, Hirawati; Dhatrak, Sarang; Ranjan Gupta, Rajeev; Ilayaperumal, Ezhilarasan; Jagjeevan, Babu; Chandra Jha, Ramesh; Kiran, K; N. Krishnan, Nivethitha; Kumar, Alok; Vinoth Kumar, VG; Nagbhushanam, K.; Arlappa, Nimmathota; Kumar Pandey, Ashok; Singh Pawar, Harpreet; Singh Rathore, Kushal; Robinson, Aby; Bhan Singh, Hari; Cheruvathoor Wilson, Vimith; Yadav, Ashwini; Yadav, Rajiv; Karunakaran, T.; Pradhan, Josephine; Sivakumar, Tharsan; Jose, Annamma; Kalaiyarasi, K; Dasgupta, Sauvik; Anusha, R; Anand, Tanu; R. Babu, Giridhara; Chauhan, Himanshu; Dikid, Tanzin; Gangakhedkar, Raman; Kant, Shashi; Kulkarni, Sanket; Muliyil, J.; Mohan Pandey, Ravindra; Sarkar, Swarup; Shrivastava, Aakash; Kumar Singh, Sujeet; Zodpey, Sanjay; Das, Aparup; Das, Pradeep; Dutta, Shanta; Kant, Rajni; Narain, Kanwar; Narasimhaiah, Somashekar; Pati, Sanghamitra; A. Patil, Shripad; Rajkumar, Hemalatha; Ramarao, Tekumalla; Sarkar, Kamalesh; Singh, Shalini; Singh Toteja, Gurudayal; Zaman, Kamran

doi:10.1016/s2214-109x(20)30544-1

Public

SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey

Published in The Lancet Global Health • Jan 27, 2021

Authors:

Manoj Murhekar

Tarun Bhatnagar

Sriram Selvaraju

Abstract

BACKGROUND: The first national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey in India, done in May-June, 2020, among adults aged 18 years or older from 21 states, found a SARS-CoV-2 IgG antibody seroprevalence of 0·73% (95% CI 0·34-1·13). We aimed to assess the more recent ...

Subject

Seroprevalence

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Coronavirus disease 2019 (COVID-19)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!